Pàgina inicial > Resultats de la cerca: Annals of Hematology
  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Dipòsit Digital de Documents de la UAB 5 registres trobats  La cerca s'ha fet en 0.01 segons. 
1.
7 p, 660.3 KB Clinical characteristics of patients with central nervous system relapse in BCR-ABL1-positive acute lymphoblastic leukemia : the importance of characterizing ABL1 mutations in cerebrospinal fluid / Sanchez, R. (Hospital 12 de Octubre (Madrid)) ; Ayala, Rosa (Hospital 12 de Octubre (Madrid)) ; Alonso, R.A. (Hospital 12 de Octubre (Madrid)) ; Martínez, M.P. (Hospital 12 de Octubre (Madrid)) ; Ribera, Jordi (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; García, Olga (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Sanchez-Pina, J. (Hospital 12 de Octubre (Madrid)) ; Mercadal, S. (ICO-Hospital Duran i Reynals (Bellvitge)) ; Montesinos, P. (Hospital Universitari i Politècnic La Fe de València) ; Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ; Barba, Pere (Hospital Universitari Vall d'Hebron) ; González-Campos, J. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Barrios, M. (Hospital Regional Universitario Carlos Haya (Málaga)) ; Lavilla, E. (Hospital Universitario Lucus Augusti (Lugo)) ; Gil, C. (Hospital General Universitario de Alicante (Alacant, País Valencià)) ; Bernal, T. (Hospital Universitario Central de Asturias) ; Escoda, Lourdes (Hospital Universitari Joan XXIII de Tarragona) ; Abella Monreal, Eugenia (Hospital del Mar (Barcelona, Catalunya)) ; Amigo, María-Luz (Hospital General Universitario Morales Meseguer (Múrcia)) ; Moreno, M.J. (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ; Bravo, P. (Hospital de Fuenlabrada) ; Guàrdia, R. (Hospital Universitari de Girona Doctor Josep Trueta) ; Hernández-Rivas, J.M. (Hospital Universitario de Salamanca) ; García-Guiñón, A. (Hospital Universitari Arnau de Vilanova) ; Piernas, Sonia (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Ribera, José Maria (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Martínez-López, J. (Hospital 12 de Octubre (Madrid)) ; Universitat Autònoma de Barcelona
We investigated the frequency, predictors, and evolution of acute lymphoblastic leukemia (ALL) in patients with CNS relapse and introduced a novel method for studying BCR-ABL1 protein variants in cDNA from bone marrow (BM) and cerebrospinal fluid (CSF) blast cells. [...]
2017 - 10.1007/s00277-017-3002-1
Annals of Hematology, Vol. 96 Núm. 7 (january 2017) , p. 1069-1075  
Registre complet - Creative Commons
2.
The PML-RARA fusion is not detectable in historical blood samples of acute promyelocytic leukaemia patients / Dunn, W.G. (Cambridge University Hospitals NHS Trust) ; Nomdedeu, Josep (Institut d'Investigació Biomèdica Sant Pau) ; Koumas, L. (Karaiskakio Foundation) ; Nicolaou, K. (Karaiskakio Foundation) ; Chi, J. (Karaiskakio Foundation) ; Costeas, P. (Cyprus Cancer Research Institute) ; Vassiliou, G.S. (Cyprus Cancer Research Institute) ; Gu, M.S. (Wellcome Trust Sanger Institute (Regne Unit)) ; Fabre, M.A. (Wellcome Trust Sanger Institute (Regne Unit)) ; Cooper, J. (Wellcome Trust Sanger Institute (Regne Unit)) ; Universitat Autònoma de Barcelona
2022 - 10.1007/s00277-021-04472-5
Annals of Hematology, Vol. 101 Núm. 2 (february 2022) , p. 443-445  
Registre complet - Creative Commons
3.
10 p, 631.8 KB Pretreatment with ibrutinib reduces cytokine secretion and limits the risk of obinutuzumab-induced infusion-related reactions in patients with CLL : analysis from the iLLUMINATE study / Greil, Richard (Salzburg Cancer Research Institute-CCCIT, Cancer Cluster Salzburg. IIIrd Medical Department Paracelsus Medical University) ; Tedeschi, Alessandra (Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy) ; Moreno, Carol (Institut d'Investigació Biomèdica Sant Pau) ; Anz, Bertrand (Tennessee Oncology. Department of Medical Oncology) ; Larratt, Loree (University of Alberta Hospital. Department of Clinical Hematology) ; Simkovic, Martin (University Hospital Hradec Kralove (República Txeca)) ; Gill, Devinder (Princess Alexandra Hospital. Department of Clinical Hematology) ; Gribben, John G. (Queen Mary University of London, Barts Cancer Institute. Centre for Haemato-Oncology) ; Flinn, Ian W. (Sarah Cannon Research Institute/Tennessee Oncology) ; Wang, Zhengyuan (Pharmacyclics LLC, an AbbVie Company. Translational Medicine) ; Cheung, Leo W. K. (Pharmacyclics LLC, an AbbVie Company. Translational Medicine) ; Nguyen, Aaron N. (Pharmacyclics LLC, an AbbVie Company. Translational Medicine) ; Zhou, Cathy (Pharmacyclics LLC, an AbbVie Company. Biostatistics) ; Styles, Lori (Pharmacyclics LLC, an AbbVie Company. Clinical Science) ; Demirkan, Fatih (Dokuz Eylül University. Department of Hematology) ; Universitat Autònoma de Barcelona
The online version contains supplementary material available at 10. 1007/s00277-021-04536-6.
2021 - 10.1007/s00277-021-04536-6
Annals of Hematology, Vol. 100 (may 2021) , p. 1733-1742  
Registre complet - Creative Commons
4.
10 p, 911.0 KB Health-related quality of life in the phase III GALLIUM study of obinutuzumab- or rituximab-based chemotherapy in patients with previously untreated advanced follicular lymphoma / Davies, A. (Cancer Research UK Centre) ; Trask, P. (Genentech Inc.) ; Demeter, J. (Semmelweis University) ; Florschütz, A. (Städtisches Klinikum Dessau) ; Hänel, M. (Klinikum Chemnitz gGmbH) ; Kinoshita, T. (Aichi Cancer Center Hospital) ; Pettengell, R. (St George's University) ; Quach, H. (St Vincent's Hospital (Sydney)) ; Robinson, S. (Bristol Haematology and Oncology Centre) ; Sadullah, S. (James Paget Hospital) ; Sancho, Juan-Manuel (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Udvardy, M. (Medical and Health Science Centre. University of Debrecen) ; Witzens-Harig, M. (Uniklinik Heidelberg) ; Knapp, A. (F. Hoffmann-La Roche Ltd) ; Liu, W. (F. Hoffmann-La Roche Ltd) ; Universitat Autònoma de Barcelona
Health-related quality of life was a secondary endpoint in the phase III GALLIUM study in previously untreated patients with follicular lymphoma who were treated with rituximab- or obinutuzumab-chemotherapy. [...]
2020 - 10.1007/s00277-020-04021-6
Annals of Hematology, Vol. 99 Núm. 12 (december 2020) , p. 2837-2846  
Registre complet - Creative Commons
5.
12 p, 548.1 KB Mosaicism in Fanconi anemia : concise review and evaluation of published cases with focus on clinical course of blood count normalization / Nicoletti, Eileen (Rocket Pharmaceuticals, Inc., New York) ; Rao, Gayatri (Rocket Pharmaceuticals, Inc., New York, NY USA) ; Bueren, Juan (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ; Río, Paula (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ; Navarro Ordóñez, Susana (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ; Surrallés i Calonge, Jordi (Institut d'Investigació Biomèdica Sant Pau) ; Choi, Grace (Rocket Pharmaceuticals, Inc., New York) ; Schwartz, Jonathan D. (Rocket Pharmaceuticals, Inc., New York) ; Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia
Fanconi anemia (FA) is a DNA repair disorder resulting from mutations in genes encoding for FA DNA repair complex components and is characterized by variable congenital abnormalities, bone marrow failure (BMF), and high incidences of malignancies. [...]
2020 - 10.1007/s00277-020-03954-2
Annals of Hematology, Vol. 99 (february 2020) , p. 913-924  
Registre complet - Creative Commons

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem